Effects of Pioglitazone in Calcific Aortic Valve Disease
Status:
Not yet recruiting
Trial end date:
2028-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, comparative, clinical trial conducted by Wuhan Union
Hospital that aims to evaluate the efficacy and safety of pioglitazone compared to placebo in
patients with calcific aortic valve disease with mild aortic valve stenosis.